{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:28:37Z","timestamp":1770517717834,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T00:00:00Z","timestamp":1415145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s11940-014-0323-4","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T19:38:46Z","timestamp":1415993926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Treatment of Mood Disorders in Multiple Sclerosis"],"prefix":"10.1007","volume":"17","author":[{"given":"Luis Pintor","family":"P\u00e9rez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto S\u00e1nchez","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Baill\u00e9s","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,5]]},"reference":[{"issue":"3","key":"323_CR1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1191\/1352458505ms1162oa","volume":"11","author":"Goldman Consensus Group","year":"2005","unstructured":"Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler. 2005;11(3):328\u201337. This article summarizes epidemiological, clinical, neurobiological, diagnostic and therapeutic aspects of depression in MS.","journal-title":"Mult Scler"},{"issue":"2","key":"323_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1212\/WNL.0000000000000013","volume":"82","author":"SL Minden","year":"2014","unstructured":"Minden SL, Feinstein A, Kalb RC, et al. Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(2):174\u201381. This article is a up-to-date review of evidence-based recommendations for screening, diagnosing and treating psychiatric disorders in MS.","journal-title":"Neurology"},{"issue":"3","key":"323_CR3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1352458508099477","volume":"15","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Horwitz R, Cutter G, et al. The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated. Mult Scler. 2009;15(3):385\u201392.","journal-title":"Mult Scler"},{"issue":"11","key":"323_CR4","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/01.WNL.0000095964.34294.B4","volume":"61","author":"SB Patten","year":"2003","unstructured":"Patten SB, Beck CA, Williams JV, et al. Major depression in multiple sclerosis: a population-based perspective. Neurology. 2003;61(11):1524\u20137.","journal-title":"Neurology"},{"key":"323_CR5","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of mental disorders, fifth edition \u2013 DSM-5","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of mental disorders, fifth edition \u2013 DSM-5. Arlington: American Psychiatric Publishing; 2013."},{"issue":"11","key":"323_CR6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1177\/1352458511417835","volume":"17","author":"A Feinstein","year":"2011","unstructured":"Feinstein A. Multiple sclerosis and depression. Mult Scler. 2011;17(11):1276\u201381.","journal-title":"Mult Scler"},{"key":"323_CR7","doi-asserted-by":"crossref","first-page":"427102","DOI":"10.5402\/2012\/427102","volume":"2012","author":"M Skokou","year":"2012","unstructured":"Skokou M, Soubasi E, Gourzis P. Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations. ISRN Neurol. 2012;2012:427102.","journal-title":"ISRN Neurol"},{"issue":"2","key":"323_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ana.21056","volume":"61","author":"HJ Rosen","year":"2007","unstructured":"Rosen HJ, Cummings J. A real reason for patients with pseudobulbar affect to smile. Ann Neurol. 2007;61(2):92\u20136.","journal-title":"Ann Neurol"},{"issue":"1","key":"323_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09540261003589323","volume":"22","author":"T Paparrigopoulos","year":"2010","unstructured":"Paparrigopoulos T, Ferentinos P, Kouzoupis A, et al. The neuropsychiatry of multiple sclerosis: focus on disorders of mood, affect and behaviour. Int Rev Psychiatry. 2010;22(1):14\u201321.","journal-title":"Int Rev Psychiatry"},{"key":"323_CR10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","volume":"76","author":"RJ Siegert","year":"2005","unstructured":"Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76:469\u201375.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11 Suppl2","key":"323_CR11","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2008.09.011","volume":"121","author":"MA Raskind","year":"2008","unstructured":"Raskind MA. Diagnosis and treatment of depression comorbid with neurologic disorders. Am J Med. 2008;121(11 Suppl2):S28\u201337.","journal-title":"Am J Med"},{"key":"323_CR12","doi-asserted-by":"crossref","DOI":"10.1017\/9780521182089","volume-title":"Stahl\u2019s essential psychopharmacology: the prescriber\u2019s guide. Antidepressants","author":"SM Stahl","year":"2011","unstructured":"Stahl SM. Stahl\u2019s essential psychopharmacology: the prescriber\u2019s guide. Antidepressants. New York: Cambridge University Press; 2011."},{"issue":"8","key":"323_CR13","doi-asserted-by":"crossref","first-page":"e42003","DOI":"10.1371\/journal.pone.0042003","volume":"7","author":"J Ramsberg","year":"2012","unstructured":"Ramsberg J, Asseburg C, Henriksson M. Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One. 2012;7(8):e42003.","journal-title":"PLoS One"},{"issue":"9665","key":"323_CR14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746\u201358.","journal-title":"Lancet"},{"issue":"1","key":"323_CR15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.genhosppsych.2007.08.002","volume":"30","author":"DM Ehde","year":"2008","unstructured":"Ehde DM, Kraft GH, Chwastiak L, et al. Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis. Gen Hosp Psychiatry. 2008;30(1):40\u20138.","journal-title":"Gen Hosp Psychiatry"},{"key":"323_CR16","volume":"2","author":"MW Koch","year":"2011","unstructured":"Koch MW, Glazenborg A, Uyttenboogaart M. Pharmacologic treatment of depression in multiple sclerosis. Cochrane Database Syst Rev. 2011;2, CD007295.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"323_CR17","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/01616412.1995.11740355","volume":"17","author":"TF Scott","year":"1995","unstructured":"Scott TF, Nussbaum P, McConnell H, et al. Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale. Neurol Res. 1995;17(6):421\u20132.","journal-title":"Neurol Res"},{"issue":"6","key":"323_CR18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1037\/0022-006X.69.6.942","volume":"69","author":"DC Mohr","year":"2001","unstructured":"Mohr DC, Boudewyn AC, Goodkin DE, et al. Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol. 2001;69(6):942\u20139.","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"323_CR19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/jnp.16.3.364","volume":"16","author":"F Benedetti","year":"2004","unstructured":"Benedetti F, Campori E, Colombo C, et al. Fluvoxamine treatment of major depression associated with multiple sclerosis. J Neuropsychiatry Clin Neurosci. 2004;16(3):364\u20136.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"4","key":"323_CR20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/WNF.0b013e3182996400","volume":"36","author":"C Solaro","year":"2013","unstructured":"Solaro C, Bergamaschi R, Rezzani C, et al. Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study. Clin Neuropharmacol. 2013;36(4):114\u20136.","journal-title":"Clin Neuropharmacol"},{"issue":"11","key":"323_CR21","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1176\/ajp.147.11.1562","volume":"147","author":"RB Schiffer","year":"1990","unstructured":"Schiffer RB, Wineman NM. Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry. 1990;147(11):1493\u20137.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"323_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/jnp.11.2.271","volume":"11","author":"Y Barak","year":"1999","unstructured":"Barak Y, Ur E, Achiron A. Moclobemide treatment in multiple sclerosis patients with comorbid depression: an open-label safety trial. J Neuropsychiatry Clin Neurosci. 1999;11(2):271\u20133.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"323_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1176\/jnp.4.2.145","volume":"4","author":"G Mattingly","year":"1992","unstructured":"Mattingly G, Baker K, Zorumski CF. Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients. J Neuropsychiatry Clin Neurosci. 1992;4(2):145\u201351.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"3","key":"323_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YCT.0b013e31806548c6","volume":"23","author":"KG Rasmussen","year":"2007","unstructured":"Rasmussen KG, Keegan BM. Electroconvulsive therapy in patients with multiple sclerosis. J ECT. 2007;23(3):179\u201380.","journal-title":"J ECT"},{"issue":"4","key":"323_CR25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/YCT.0b013e3181d039e6","volume":"26","author":"TK Pontikes","year":"2010","unstructured":"Pontikes TK, Dinwiddie SH. Electroconvulsive therapy in a patient with multiple sclerosis and recurrent catatonia. J ECT. 2010;26(4):270\u20131.","journal-title":"J ECT"},{"issue":"4","key":"323_CR26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/13554794.2013.791865","volume":"20","author":"M Urban-Kowalczyk","year":"2014","unstructured":"Urban-Kowalczyk M, Rudecki T, Wr\u00f3blewski D, et al. Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis. Neurocase. 2014;20(4):452\u20135.","journal-title":"Neurocase"},{"key":"323_CR27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-244X-14-5","volume":"14","author":"D Hind","year":"2014","unstructured":"Hind D, Cotter J, Thake A, Bradburn M, Cooper C, Isaac C, et al. Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis. BMC Psychiatry. 2014;14:5. This article is a up-to-date review of evidence-based recommendations for CBT in depressive disorders in MS.","journal-title":"BMC Psychiatry"},{"key":"323_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269215509343492","volume":"24","author":"AC Forman","year":"2010","unstructured":"Forman AC, Lincoln NB. Evaluation of an adjustment group for people with multiple sclerosis: a pilot randomized controlled trial. Clin Rehabil. 2010;24:211\u201321.","journal-title":"Clin Rehabil"},{"key":"323_CR29","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/1352458511408753","volume":"17","author":"NB Lincoln","year":"2011","unstructured":"Lincoln NB, Yuill F, Holmes J, Drummond AE, Constantinescu CS, Armstrong S, et al. Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial. Mult Scler. 2011;17:1250\u20137.","journal-title":"Mult Scler"},{"issue":"9","key":"323_CR30","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/archpsyc.62.9.1007","volume":"62","author":"DC Mohr","year":"2005","unstructured":"Mohr DC, Hart SL, Julian L, et al. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry. 2005;62(9):1007\u201314.","journal-title":"Arch Gen Psychiatry"},{"key":"323_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1745-6215-12-259","volume":"12","author":"CL Cooper","year":"2011","unstructured":"Cooper CL, Hind D, Parry GD, Isaac CL, Dimairo M, O\u2019Cathain A, et al. Computerised cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: external pilot trial. Trials. 2011;12:259.","journal-title":"Trials"},{"key":"323_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2377-14-15","volume":"14","author":"R Simpson","year":"2014","unstructured":"Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S. Mindfulness based interventions in multiple sclerosis - a systematic review. BMC Neurol. 2014;14:15.","journal-title":"BMC Neurol"},{"issue":"6","key":"323_CR33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0163-8343(00)00100-6","volume":"22","author":"N Mills","year":"2000","unstructured":"Mills N, Allen J. Mindfulness of movement as a coping strategy in multiple sclerosis: a pilot study. Gen Hosp Psychiatry. 2000;22(6):425\u201331.","journal-title":"Gen Hosp Psychiatry"},{"issue":"13","key":"323_CR34","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/WNL.0b013e3181f4d80d","volume":"75","author":"P Grossman","year":"2010","unstructured":"Grossman P, Kappos L, Gensicke H, D\u2019Souza M, Mohr DC, Penner IK, et al. MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial. Neurology. 2010;75(13):1141\u20139.","journal-title":"Neurology"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-014-0323-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-014-0323-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-014-0323-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T10:30:41Z","timestamp":1650623441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-014-0323-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["323"],"URL":"https:\/\/doi.org\/10.1007\/s11940-014-0323-4","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,5]]},"article-number":"323"}}